Harnessing the immune system in the treatment of cutaneous T cell lymphomas
Cutaneous T cell lymphomas are a rare subset of non-Hodgkin’s lymphomas with predilection for the skin with immunosuppressive effects that drive morbidity and mortality. We are now appreciating that suppression of the immune system is an important step in the progression of disease. It should come a...
Main Authors: | Christopher J. Fay, Katherine C. Awh, Nicole R. LeBoeuf, Cecilia A. Larocca |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2022.1071171/full |
Similar Items
-
Evaluation of the Cutaneous Lymphoma International Prognostic Index in patients with early stage mycosis fungoides
by: Gustavo Moreira Amorim, et al.
Published: (2018-10-01) -
Epidemiology of Cutaneous T-Cell Lymphomas: A Systematic Review and Meta-Analysis of 16,953 Patients
by: Gabor Dobos, et al.
Published: (2020-10-01) -
Pachyderma in Primary Cutaneous NK and T-Cell Lymphoma and Leukemia Cutis
by: Eve Lebas, et al.
Published: (2017-09-01) -
Cutaneous lymphomas: An update
by: Ashok Singh, et al.
Published: (2014-01-01) -
Cutaneous T-cell lymphoma: Differential diagnostics of erythrodermic conditions
by: A. E. Karamova, et al.
Published: (2019-12-01)